AbbVie Inc. (ABBV) vs Tokio Marine Holdings, Inc. (TKOMY)

See how AbbVie Inc. and Tokio Marine Holdings, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$267.65
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page
$50.5
OTC Markets OTCPK
View Full Page

Key Metrics Comparison

AbbVie Inc.ABBV
Market Cap
$472.969B
Price
$267.65
24h Change
+0.71%
24h Volume
$1.29M
Employees
57,000
Shares Outstanding
1,768,169,012
Tokio Marine Holdings, Inc.TKOMY
Market Cap
$1.431T
Price
$50.5
24h Change
+1.84%
24h Volume
$54.3K
Employees
67,526
Shares Outstanding
N/A

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ABBV
24.8%
TKOMY
75.2%

Volume Share

Share of combined 24h volume

Volume Share
ABBV
95.9%
TKOMY
4.1%

24h Performance

Price change over last 24 hours

24h Performance
ABBV
0.71%
TKOMY
1.84%
Price Comparison
AbbVie Inc.
Tokio Marine Holdings, Inc.